Skip to content
10-K

Annual Report

PALISADE BIO, INC. PALI

0000950170-25-043859

← back to feed
Filed
Mar 24, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 19, 2025 4.4M sh
Capex FY 2024 · Dec 31, 2024 $0
Capex FY 2024 · Dec 31, 2023 $4K
Revenue FY 2024 · Dec 31, 2024 $0
Revenue FY 2024 · Dec 31, 2023 $250K
Shares Diluted restated FY 2024 · Dec 31, 2023 456.01K sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$11.13M
Cash And Equivalents FY 2024 · Dec 31, 2023 $12.43M
Current Liabilities FY 2024 · Dec 31, 2023 $2.59M
Total Liabilities FY 2024 · Dec 31, 2023 $2.74M
Current Assets FY 2024 · Dec 31, 2023 $13.33M
Total Assets FY 2024 · Dec 31, 2023 $14.05M
Eps Diluted restated FY 2024 · Dec 31, 2023 −$27.01
Eps Basic restated FY 2024 · Dec 31, 2023 −$27.01
Net Income FY 2024 · Dec 31, 2023 −$12.3M
Operating Income FY 2024 · Dec 31, 2023 −$13.07M
Stockholders Equity FY 2024 · Dec 31, 2022 $12.48M